Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Patent
1989-03-13
1998-03-03
Berch, Mark L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
544243, 544244, 544276, 544314, 544317, 544254, 544265, 560231, A61K 3152, C07D47318, C07D47316, C07D47332
Patent
active
057236097
ABSTRACT:
Antiviral activity is exhibited by compounds having the formula ##STR1## and its pharmaceutically acceptable salts wherein R.sub.1 is ##STR2## wherein R.sub.2 is hydrogen, methyl, fluoro, chloro, bromo, iodo, hydroxy or amino; or trifluoromethyl; R.sub.5 is alkyl; R.sub.6 is hydrogen, alkyl, substituted alkyl, or aryl; and R.sub.7 and R.sub.8 are independently hydrogen, ##STR3##
REFERENCES:
patent: 4177348 (1979-12-01), Shealy et al.
patent: 4232154 (1980-11-01), Shealy et al.
patent: 4617304 (1986-10-01), Ashton et al.
patent: 4743689 (1988-05-01), Shimada et al.
patent: 4782062 (1988-11-01), Tolman et al.
patent: 4801710 (1989-01-01), MacCoss et al.
patent: 4845215 (1989-07-01), Shimada et al.
patent: 4855466 (1989-08-01), Zahler et al.
patent: 4918075 (1990-04-01), Zahler et al.
patent: 4968674 (1990-11-01), Taniyama et al.
patent: 5064961 (1991-11-01), Bisacchi et al.
E. De Clercq et al, Targets for the Design of Antiviral Agents, pp. 203-230 (1983).
Mark J. Bainford et al, J. Med. Chem. 1990, 33, pp. 2494-2051.
Akira Kono et al, Chem. Pharm. Bull. 32(5) 1919-1921 (1984).
De Clercq, et al., Nucleosides and Nucleotides, vol. 8(5 & 6), pp. 659-671 (1989).
Vince, et al., J. Med. Chem., vol. 33(1), pp. 17-21 (Jan. 1990).
Walton, "3-Methylenecyclobutyl, Cyclopent-3-enyl . . . ", J. Chem. Soc. Perkin Trans II, 1987, pp. 231-235. 121, 1988, pp. 1013-1016.
Hanack et al., "Solvolusen con delta.sup.2 . . . ", Chemische Berichte, vol. 100, 1967, pp. 2107-2116.
Elion et al, Proc. Natl. Acad. Sci., USA, vol. 74, pp. 5716-5720, Dec. 1977.
Mitsuya et al, Proc. Natl. Acad. Sci., USA, vol. 82, pp. 7096-7100, Oct. 1985.
N. Shimada et al., Oxetanocin, A Novel Nucleoside from Bacteria, Nov. 1986, J. Antibiotics 39, p. 1623.
H. Nakamura et al., The X-Ray Structure Determination of Oxetanocin, Nov. 1986, J. Antibiotics, 39, p. 1626.
H. Hoshino et al., Inhibition of Infectivity of Human Immunodeficiency Virus by Oxetanocin, Jul. 1987, J. Antibiotics, 40, p. 1077.
S. Niitsuma et al., Studies on the Total Synthesis of Oxetanocin, The First Synthesis of a Nucleoside Having Oxetanosyl-N-Glycoside.sup.1, Tetrahedron Letters, vol. 28, pp. 3967-3970, May 1987.
S. Niitsuma et al., Studies on the Total Synthesis of Oxetanocin; Tetrahedron Letters, vol. 28, pp. 4713-4714, May 1987.
G. N. Austin et al., Chiral Oxetanes from Sugar Lactones, Tetrahedron Letters, vol. 28, pp. 4741-4744, May 1987.
N. Shimada--Derivatives of Oxetanocin: Oxetanocins, H, X and G, and 2-Aminooxetanocin A, J. Antibiotics, vol. 40, p. 1789, Dec. 1987.
Marquez, et al. Medicinal Research Reviews, vol. 6, No. 1, John Wiley & Sons, Inc., 1986, pp. 1-16 and 36-40.
Slusarchyk William A.
Zahler Robert
Berch Mark L.
Davis Stephen B.
E. R. Squibb & Sons Inc.
LandOfFree
Bis (hydroxymethyl) cyclobutyl purines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis (hydroxymethyl) cyclobutyl purines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis (hydroxymethyl) cyclobutyl purines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2249040